The global choline bitartrate market is slated to expand at a substantial rate through 2028 due to rising awareness pertaining to product prominence in the food & beverage sector.

Choline is essential for various biological functions and may provide a variety of other health advantages. Notably, it is a vitamin that is considered vital for brain development. Recent research papers have exhibited the benefits of choline supplements, thereby fostering product outlook. For instance, an October 2021 study showed that people aged over 60 years with higher choline levels exhibit better cognitive functioning than those with a lower level of choline.

Moreover, certain studies have also found that choline could aid fat metabolism, which is why it is predominantly used in dietary supplements. Thus, due to these benefits, choline bitartrate is widely used in numerous industries, such as pharmaceuticals, dietary supplements, baby food, and others.

The U.S. Food and Drug Administration (FDA) mandates that infant formula that is not generated from cow’s milk should be combined with choline since formulas created from non-animal sources, especially soy, have significantly smaller amounts of choline concentrations than human milk. As a result, increasing use of choline in baby food production has propelled choline bitartrate market growth in the past few years.

Furthermore, most people’s diets do not contain the necessary levels of choline. Even when the amount of choline present in dietary supplements and food is combined, overall choline intakes fall below the required levels, which has raised consumer interest in the product.

Even though most people do not consume the necessary quantities of choline, only few people experience symptoms of choline shortage. One reason for this could be that the human body produces some amount of choline. However, if a person’s choline levels become too low, it may lead to muscle and liver damage as well as cause fat deposits in the liver, which is a condition called nonalcoholic fatty liver disease that can harm the organ. Subsequently, increased research and development activities to develop better choline nutritional supplements have positively impacted the product landscape of the choline bitartrate market.

Several major players in the choline bitartrate industry have been adopting lucrative strategies to improve their industry standing. In addition, to extend their product offerings to consumers in leading regions, companies are relying on undertaking supply chain partnerships with distributors and dealers, which has bolstered industry progress.

For comprehensive assessment, the choline bitartrate market has been bifurcated in terms of type, application, and region. From the regional standpoint, the Middle East & Africa choline bitartrate industry holds a substantial market share and is expected to grow at a CAGR of around 4.5% over the forecast timeline to exceed a valuation of USD 15 million by 2028.